-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Observational research results indicate that low levels of vitamin D may be a risk factor for cancer.
Recently, the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, published a research article that sought to determine whether vitamin D supplementation can reduce the risk of cancer and precancerous diseases.
The D2d Cancer Outcome Study (D2dCA) was completed in 22 academic medical centers in the United States to explore the correlation between vitamin D levels and type 2 diabetes (D2d).
During a median follow-up of 2.
It can be seen that for people with prediabetes and overweight/obesity, vitamin D supplementation has no significant effect on the risk of cancer or colon polyps .
For people with prediabetes and overweight/obesity, vitamin D supplementation has no significant effect on the risk of cancer or colon polyps
Original source:
Original source:Ranee Chatterjee.
org/10.
1210/clinem/dgab153" target="_blank" rel="noopener">Vitamin D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study in this message